New Studies Question Utility of Gene Expression Testing for Cancers With Unknown Primary Site, Low-Risk Breast Cancer

New Studies Question Utility of Gene Expression Testing for Cancers With Unknown Primary Site, Low-Risk Breast Cancer

From - Diagnostic Testing & Emerging Technologies
Gene expression profiling has been making inroads into clinical cancer care, with application in cancer classification, most notably with…


. . . read more

This content is for Paid Members only.
Login Register
Current Metal Sensitivity Testing Not Adequate for Diagnosing Immune-Related Knee Replacement Failure

Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy

From - Diagnostic Testing & Emerging Technologies
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to…


. . . read more

This content is for Paid Members only.
Login Register